WallStreetZenWallStreetZen

NYSE: NGVT
Ingevity Corp Stock

Overview
ForecastEarningsRevenueDividendOwnership
$69.15-1.39 (-1.97%)
Updated Sep 8, 2026
NGVT Price
$69.15
Fair Value Price
N/A
Market Cap
$2.38B
52 Week Low
$45.85
52 Week High
$79.28
P/E
43.77x
P/B
50.69x
P/S
2.24x
PEG
0.5x
Dividend Yield
N/A
Revenue
$1.16B
Earnings
$54.00M
Gross Margin
41.1%
Operating Margin
11.8%
Profit Margin
4.7%
Debt to Equity
31.78
Operating Cash Flow
$211M
Beta
1.23
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

NGVT Overview

Ingevity Corporation manufactures specialty chemicals and activated carbon materials. Its Performance Chemicals segment manufactures chemicals used in processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment offers carbon products used in automobiles. Ingevity was founded in 1964 and is headquartered in North Charleston, SC.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine NGVT's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +17.17% per year. Learn More
View All “A” Zen Rated Stocks
→

Zen Rating Component Grades

C
Value
C
Growth
C
Momentum
B
Sentiment
C
Safety
A
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Specialty Chemical

Industry Rating
A
NGVT
Ranked#13 of 51

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
Sasol (SSL)
$13.30A
Kronos Worldwide (KRO)
$8.63A
Alto Ingredients (ALTO)
$4.11A
View Top Specialty Chemical Stocks

Be the first to know about important NGVT news, forecast changes, insider trades & much more!

NGVT News

Overview

Due Diligence Score

–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NGVT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NGVT ($69.15) is trading above its intrinsic value of $51.46, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NGVT is poor value based on its earnings relative to its share price (43.77x), compared to the US market average (41.18x)
P/E vs Market Valuation
NGVT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more NGVT due diligence checks available for Premium users.

Valuation

NGVT price to earnings (PE)

For valuing profitable companies with steady earnings

Company
43.77x
Industry
-91.92x
Market
41.18x
NGVT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
NGVT is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

NGVT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
50.69x
Industry
3.6x
NGVT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NGVT price to earnings growth (PEG)

For valuing profitable companies with growth potential

NGVT is good value based... subscribe to Premium to read more.
PEG Value Valuation

NGVT's financial health

Profit margin

Revenue
$314.1M
Net Income
$35.3M
Profit Margin
11.2%
NGVT's Earnings (EBIT) of $136.90M... subscribe to Premium to read more.
Interest Coverage Financials
NGVT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.5B
Liabilities
$1.5B
Debt to equity
31.78
NGVT's short-term assets ($543.80M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NGVT's long-term liabilities ($1.15B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NGVT's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
NGVT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$13.8M
Investing
$75.4M
Financing
-$37.6M
NGVT's operating cash flow ($211.00M)... subscribe to Premium to read more.
Debt Coverage Financials

NGVT vs Specialty Chemical Stocks

TickerZen RatingMarket Cap1d %P/EP/B
NGVTB$2.38B-1.97%43.77x50.69x
CCC$2.33B+0.98%-7.69x-47.45x
IOSPA$2.30B-0.62%19.02x1.71x
MTXC$2.20B-1.73%-32.20x1.42x
HWKNC$2.65B-1.65%32.73x4.84x
View Top Specialty Chemical Stocks

Ingevity Stock FAQ

What is Ingevity's quote symbol?

(NYSE: NGVT) Ingevity trades on the NYSE under the ticker symbol NGVT. Ingevity stock quotes can also be displayed as NYSE: NGVT.

If you're new to stock investing, here's how to buy Ingevity stock.

What is the 52 week high and low for Ingevity (NYSE: NGVT)?

(NYSE: NGVT) Ingevity's 52-week high was $79.28, and its 52-week low was $45.85. It is currently -12.78% from its 52-week high and 50.82% from its 52-week low.

How much is Ingevity stock worth today?

(NYSE: NGVT) Ingevity currently has 34,377,922 outstanding shares. With Ingevity stock trading at $69.15 per share, the total value of Ingevity stock (market capitalization) is $2.38B.

Ingevity stock was originally listed at a price of $26.86 in May 16, 2016. If you had invested in Ingevity stock at $26.86, your return over the last 10 years would have been 157.45%, for an annualized return of 9.92% (not including any dividends or dividend reinvestments).

How much is Ingevity's stock price per share?

(NYSE: NGVT) Ingevity stock price per share is $69.15 today (as of Sep 8, 2026).

What is Ingevity's Market Cap?

(NYSE: NGVT) Ingevity's market cap is $2.38B, as of Sep 9, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Ingevity's market cap is calculated by multiplying NGVT's current stock price of $69.15 by NGVT's total outstanding shares of 34,377,922.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.